GTGebrehiwot Teklay

Gebrehiwot Teklay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gebrehiwot Teklay has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metformin dose up-titration and glycemic control in type 2 diabetes in a resource-limited setting, northern Ethiopia: a retrospective cohort study

    by Gebrehiwot Teklay, Halefom Tafere, Yirga Legesse Niriayo

    Metformin is the preferred initial therapy for type 2 diabetes mellitus (T2DM) and gradual upward dose titration is recommended to reach target blood glucose levels. The aim of this study was to assess the pattern of metformin dose up-titration and its effect on glycemic control among T2DM patients. A retrospective cohort study of people with T2DM was conducted at Ayder Comprehensive Specialized Hospital from January to March 2020. Participants with fasting plasma glucose above 140 mg/dl after one month of initiating metformin were followed over the course of treatment. Multivariable binary logistic regression models were used to evaluate independent variables associated with metformin dose up-titration and glycemic control. The output of the logistic regression was expressed as adjusted odds ratios at 95% confidence intervals. Test results were considered statistically significant when p < 0.05. A total of 284 T2DM patients on metformin were included in the study. The mean age and SD of the study participants was 54.0 ± 10.5. Metformin dose was up-titrated at least once in 61.6% of the study participants. Almost half of the study participants had achieved glycemic control (HbA1c ≤ 7). Having a duration of treatment less than five years, initiating metformin at a daily dose of 500 mg and the addition of hypoglycemic medications were independent predictors of metformin dose up-titration. T2DM patients whose metformin dose was up-titrated had two times higher odds of having controlled blood glucose levels compared to those not up-titrated (P-value: 0.015; OR: 1.823; 95% CI: 1.121-2.963). A gradual metformin dose titration at later than the 4th month was associated with better glycemic control. T2DM patients whose metformin dose was titrated only once were less likely to achieve glycemic control (P-value: 0.038; OR: 0.482; 95% CI: 0.242-0.962). In this resource-constrained setting, metformin dose up-titration was less commonly practiced than adding another hypoglycemic agent in the management of T2DM. However, dose up-titration was associated with a higher likelihood of achieving glycemic control. These findings suggest that optimizing metformin dosing may improve glycemic outcomes before intensifying therapy with additional agents, although prospective studies are needed to confirm this association. Not applicable.

  • Open Access

    Antibiotic prescribing for outpatients with respiratory tract infections in public and private clinics of a resource-constrained setting, northern Ethiopia: a cross-sectional study

    by Gebrehiwot Teklay, Hailemelecot Yohannes

    Respiratory tract infections (RTIs) are the most common reason for antibiotic prescribing and overuse. Ethiopia is a country with a high burden of acute RTIs, and the pattern of antibiotic prescribing has not been thoroughly studied. This study aimed to compare the patterns of antibiotic prescribing for RTI in public and private outpatient clinics in Mekelle, northern Ethiopia. A cross-sectional study was conducted by reviewing filled prescriptions. The participants were adult outpatients with RTIs such as acute bronchitis, common cold, nonspecific upper respiratory infections, pharyngitis/tonsillitis and community acquired pneumonia, from both public and private clinics. Prescription concordance with treatment guidelines was assessed based on national treatment guideline. Patterns of antibiotic prescribing were described by the WHO AWaRe classification of antibiotics. A two proportion Z test and binary logistic regression analysis were used to compare antibiotic prescription rates in public and private clinics. The results of the logistic regression were expressed as odds ratios with 95% confidence intervals. A p value of less than 0.05 was considered statistically significant. A total of 320 participants were included in the study, with approximately half (51.3%) being male. The proportion of antibiotic prescriptions for RTIs was 75.3% (private, 70.7% and public, 80.1%). According to the WHO AWaRe classification, prescriptions containing Access and Watch antibiotics were 79.7% and 20.3%, respectively. The most commonly prescribed antibiotics were amoxicillin and amoxicillin-clavulanic acid. Among antibiotic prescriptions for community acquired pneumonia, acute bronchitis, common cold and nonspecific upper respiratory infections, 22% were not in accordance with the guidelines. The odds of receiving a non-concordant prescription, broad-spectrum antibiotic, brand name prescription or having an upper RTI were higher in participants who visited a private clinic compared to public clinic (p < 0.05). This study has identified the presence of a high antibiotic prescribing rate for outpatients with RTIs. Patients visiting the private sector were more likely to receive prescriptions non-concordant with guidelines, with brand names, and broad-spectrum antibiotics. Decision makers in the private sector should be actively involved in promoting the responsible use of antimicrobials to prevent antimicrobial resistance.


  • Open Access

    Appropriateness of antibiotic prescribing among patients treated for dental diseases in Mekelle city, Northern Ethiopia: a cross sectional study

    by Gebrehiwot Teklay, Haftu Tefera

    Local operative treatments are generally preferred for most dental diseases, with antibiotics only recommended as an adjunct in specific cases. Misuse and overuse of antibiotics has been shown to significantly contribute to the development of resistant bacteria. However, the antibiotic prescribing practices of dentists in Ethiopia have not been thoroughly studied. This study aimed to assess the appropriateness of antibiotic prescribing for patients with dental diseases at dental clinics in Mekelle City, Northern Ethiopia. A cross sectional study was conducted in April and May 2020 among patients visiting dental clinics in Mekelle City. Data were collected through patient medical record reviews and dentist interviews. The appropriateness of antibiotic prescription was evaluated based on guidelines from the American Dental Association and the European Society of Endodontology. Data were analyzed using SPSS Statistics, version 29. Binary logistic regression analysis was performed, and the results were presented as odds ratios with 95% confidence intervals. A p value less than 0.05 was considered statistically significant. Two hundred and thirty-one patients with dental diseases participated in the study. The mean age was 30.6 years with a standard deviation of 16.1. Most participants had dental pulp related disease. 89% of patients were prescribed antibiotics, with amoxicillin being the most common. Inappropriate antibiotic prescribing was identified in 175 (75.8%) of the study participants. The most common inappropriate prescribing was unnecessary antibiotic prescribing for dental conditions without systemic signs, assessed in 141 (80.1%) participants. Patients diagnosed with pulp related disease without systemic signs and those who had tooth extractions were significantly associated with inappropriate antibiotic prescription (p value < 0.001). The study findings show that antibiotics are over-prescribed for dental conditions in this resource constrained setting, especially in patients who have had tooth extractions. Dentists need training on appropriate antibiotic use and antimicrobial stewardship interventions should be implemented in dental setting to reduce unnecessary antibiotic prescriptions and prevent antibiotic resistance development.


  • Open Access

    Brief communication: reasons for non-adherence of co-trimoxazole prophylaxis therapy among people living with HIV in a resource-limited setting, Northern Ethiopia

    by Gebrehiwot Teklay, Meryem Mohammedbrhan, Desilu Mahari Desta

    This study aimed to assess the prevalence and reasons for nonadherence to cotrimoxazole prophylaxis therapy. A cross-sectional study was conducted among people living with HIV attending Ayder Comprehensive Specialized Hospital. Data were collected through interviews and reviews of medical records. Binary logistic regression was employed to analyze factors associated with CPT nonadherence. Approximately two-thirds (65.5%) of the participants were non-adherent to co-trimoxazole prophylaxis therapy. The main reasons for non-adherence were side effects, pill fatigue and forgetfulness. Strategies to improve adherence to co-trimoxazole prophylaxis therapy should focus on the combined patient, clinical and medication related issues of people living with HIV.

  • Open Access

    Cotrimoxazole Prophylaxis Therapy Uptake and Reasons for Nonadherence among People Living with HIV in Ayder Comprehensive Specialized Hospital, Tigray, Northern Ethiopia: A Cross-sectional Study

    by Gebrehiwot Teklay, Meryem Mohammedbrhan

    Background: Cotrimoxazole prophylaxis therapy (CPT) is one of the interventions recommended to be implemented as an integral component of a package of HIV-related services. The effectiveness of CPT in reducing mortalities and morbidities associated with opportunistic infections is well demonstrated. Studies to explore the level of uptake and barriers to cotrimoxazole prophylaxis adherence over a course of ART are necessary. This study aimed to assess the prevalence and reasons for nonadherence to cotrimoxazole prophylaxis therapy among people living with HIV (PLHIV). Methods: A health facility-based cross-sectional study was conducted among PLHIV in Ayder Comprehensive Specialized Hospital from April to May 2020. Data were collected through interviews and reviews of medical records. Data were analyzed using SPSS version 20.0 statistical software. Binary logistic regression was used to analyze factors associated with cotrimoxazole prophylaxis therapy nonadherence, and the output of the logistic regression was expressed as odds ratios at 95% confidence intervals. P values of less than 0.05 were considered statistically significant. Results: One hundred and seventy-seven participants were included in this study. Nearly half (53.1%) of the participants were female, and the majority (72.9%) were aged between 31 and 59. One hundred sixteen (65.5%) participants were nonadherent to CPT. The main reasons for nonadherence were side effects, pill fatigue and forgetfulness. PLHIV with CD4 counts > 350 were 3.48 times more likely to interrupt CPT by themselves than those with CD4 counts ≤ 350 (P value = 0.002; AOR, 3.481; 95% CI, 1.555–7.792). PLHIV who were adherent to ART were 72.1% less likely to be nonadherent to CPT compared with those who were nonadherent to ART (P value = 0.001; AOR, 0.279; 95% CI, 0.128–0.608). PLHIV who experienced side effects were 3.85 times more likely to be nonadherent to CPT than those who did not experience side effects (P value = 0.001; AOR, 3.849; 95% CI, 1.789–8.284). Conclusions: Significant numbers of PLHIV were nonadherent to CPT mainly due to side effects, pill fatigue and forgetfulness. Strategies to improve adherence to CPT should focus on the combined patient- and medication-related problems of PLHIV.

  • Open Access

    Treatment optimization of angiotensin converting enzyme inhibitors and associated factors in Ayder Comprehensive Specialized Hospital: a cross-sectional study

    by Tesfay Mehari Atey, Tsegay Teklay, Solomon Weldegebreal Asgedom, Haftay Berhane Mezgebe, Gebrehiwot Teklay, Molla Kahssay

    Angiotensin-converting enzyme inhibitors have morbidity and mortality benefits in heart failure. Failure to optimize treatment using these medications increases hospitalizations, worsens signs and symptoms of heart failure, and reduces the overall treatment outcome. Therefore, the main purpose of this study was to assess the practice of treatment optimization of these medications and associated factors. A hospital-based cross-sectional study was conducted on 61 ambulatory heart failure patients, recruited using a convenience sampling technique, from February 25 to May 24, 2016 at the cardiology clinic of Ayder Comprehensive Specialized Hospital. Descriptive, inferential and Kaplan–Meier ‘tolerability’ analyses were employed. All patients were taking only enalapril as part of their angiotensin converting enzyme inhibitor treatment. According to the 2013 American College of Cardiology/American Heart Association guideline, about fourth-fifth (80.3%) of the patients were tolerating to the hypotensive effect of enalapril. The dose of enalapril was timely titrated (every 2–4 weeks) and was optimized for only 11.5 and 27.8% of the patients, respectively. Considering the tolerance, timely titration, and dose optimization, only 3.3% of the overall enalapril treatment was optimized. Multivariate regression results showed that the odds of having timely titration of enalapril for patients who were taking enalapril and calcium channel blockers were almost 20 times [adjusted odds ratio (AOR) = 21.68, 95% confidence interval (CI) 1.23–383.16, p < 0.036] more compared to patients who were taking enalapril and β-blockers. A Log Rank Chi Square result showed a 19.42 magnitude of better toleration of enalapril (p < 0.001) for patients who were taking enalapril for more than 1 year compared to less than a year. This study provides a platform for assessment of the treatment optimization practice of enalapril, which remains the pressing priority and found to be poor in the ambulatory setting, despite a better tolerability to the hypotensive effect of enalapril. We call for greater momentum of efforts by health care providers in optimizing the treatment practice to benchmark with other optimization practices.


  • Open Access

    Potential drug–drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study

    by Fantaye Teka, Gebrehiwot Teklay, Eskindeir Ayalew, Terefe Teshome

    The elderly are considered as special population, as they differ from younger adults in terms of comorbidity, polypharmacy, pharmacokinetics, vulnerability to drug–drug interactions and adverse drug reactions. Despite the fact that the elderly patients are at high risk of having drug interaction and potential adverse outcomes, studies in this regard are scarce in resource limited settings like Ethiopia. The aim of this study was to assess the prevalence and determinants of potential drug–drug interaction in elderly patients admitted to medical ward of Ayder Referral Hospital in Northern Ethiopia. A cross sectional study was conducted among elderly inpatients aged 60 years and above. The study was conducted from February to May 2014. Prescribed drugs being taken concurrently for at least 24 h were included and checked for drug–drug interaction using Micromedex® 2.0 online drug reference. Data were analyzed using statistical software, statistical package for social sciences for windows version 20. Logistic regression model was used to analyze factors associated with occurrence of drug interaction. P value of <0.05 was considered statistically significant. A total of 140 patients were participated in the study. The mean age (±standard deviation) of participants was 68 (±7) years. Majority (61.4 %) of patients were diagnosed with cardiovascular and/or renal diseases. A total of 814 drugs were prescribed with a mean of 6 (±4) medications per patient during a 13 (±9) days of hospital stay. About two-third (62.2 %) of the respondents were exposed to at least one potential drug–drug interaction. Among these 3.6, 32.9 and 25.7 % of patients had taken contraindicated drug combination, at least one major and at least one moderate drug–drug interaction, respectively. Patients with five or more prescribed medications were four times at risk of having drug–drug interaction (P = 0.00; adjusted odds ratio 4.047; 95 % confidence interval 1.867–8.775). Drug–drug interaction in elderly patients was common in this resource limited set-up. Awareness creation and clinical pharmacist involvement in minimizing the risk associated with potentially harmful drug combinations are needed.


  • Open Access

    Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study

    by Gebrehiwot Teklay, Tsigemariam Teklu, Befikadu Legesse, Kiros Tedla, Eveline Klinkenberg

    Isoniazid preventive therapy is a key public health intervention for the prevention of tuberculosis disease among people living with HIV. Despite the confirmed efficacy of isoniazid preventive therapy and global recommendations existing for decades, its implementation remains limited. In resource constrained settings, few have investigated why isoniazid preventive therapy is not implemented on full scale. This study was designed to investigate the level of isoniazid preventive therapy implementation and reasons for suboptimal implementation in Tigray region of Ethiopia. A review of patient records combined with a qualitative study using in-depth interviews and focus group discussions was conducted in 11 hospitals providing isoniazid preventive therapy in the Tigray Region. The study participants were health providers working in the HIV clinics of the 11 hospitals in the province. Health providers were interviewed about their experience of providing isoniazid preventive therapy and challenges faced during its implementation. All conversations were audio-recorded. Record review of 16,443 HIV patients registered for care in these hospitals between September 2011 and April 2014 was done to determine isoniazid preventive therapy utilization. Data were collected from April to August 2014. Fifty health providers participated in the study. Overall isoniazid preventive therapy coverage of the region was estimated to be 20 %. Isoniazid stock out, fear of creating isoniazid resistance, problems in patient acceptance, and lack of commitment of health managers to scale up the program were indicated by health providers as the main barriers hindering implementation of isoniazid preventive therapy. Implementation of isoniazid preventive therapy in Tigray region of Ethiopia had low coverage. Frequent interruption of isoniazid supplies raises the concern of interrupted therapy resulting in creation of isoniazid resistance. Health managers, drug suppliers and partners working in HIV and tuberculosis programs should be committed to ensure an uninterrupted supply of isoniazid and full scale implementation of isoniazid preventive therapy to eligible people living with HIV.